RemAb Therapeutics is a biopharmaceutical company whose main activities and expertise are related, among others, to the identification, characterization and selective removal of specific antibodies (HART-Technology) for offering health solutions in the field of infectious diseases, allergology, autoimmunity, transplantation and transfusion medicine, and modulation of the human immune responses against viral vectors.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Av. De Can Domènech S/n, Lab Mrb/11,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- remabtx.com
- Keywords
- Pamplona.
- HQ
- Cerdanyola del Vallès, Barcelona
Remab Therapeutics Questions
Remab Therapeutics's website is remabtx.com
Remab Therapeutics's LinkedIn profile is https://es.linkedin.com/company/remabtx
Remab Therapeutics has
6 employees.
View email and phone details for 6
employees at Remab Therapeutics.
Remab Therapeutics's industry is
Biotechnology Research
Remab Therapeutics's top competitors are
Connecta Therapeutics,
Stab Therapeutics,
Bioclonal,
Inhibitec Anticuerpos, S.l.,
Oxolife,
Lainco Pharma,
A4cell,
Mimo Biosciences,
Ahead Therapeutics,
Gp-Pharm.
Remab Therapeutics's categories are Biotechnology Research
Remab Therapeutics's founding year is 2018
